AnRes Clinical ApS: Financial statements 2023
CVR: 41147504
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
AnRes Clinical ApS (CVR 41147504) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 1,131,891 and a net result of DKK 116,961 compared with DKK 102,006 the year before. That is a decrease of 18.9% compared with the year before. Equity in the 2023 report amounted to DKK 1,090,448. The solvency ratio was 82.9%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 1,131,891
- Profit/Loss
- DKK 116,961
- Equity
- DKK 1,090,448
- Total Assets
- DKK 1,315,160
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 1.1M | 117K | 1.1M | 2 |
| 2022 | - | 1.4M | 102K | 973K | 3 |
| 2021 | - | 1.2M | 394K | 871K | 2 |
| 2020 | - | 806K | 438K | 478K | 2 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
AnRes Clinical ApS has published its annual report for 2022. Gross profit came to DKK 1,395,131, and the net result was DKK 102,006.
About AnRes Clinical ApS
AnRes Clinical ApS is a Danish company of the type Anpartsselskab based in Vejle, founded in 2020. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Anna Katarzyna Polak. The company is owned by Anna Katarzyna Polak. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 1,457,177 and a net result of DKK 286,285 compared with DKK 1,120,314 the year before. Equity in the 2025 report amounted to DKK 2,306,048.